On July 8 a study went around that most health system leaders scrolled past. A randomized trial, published in Nature Medicine, tested a generative AI tool built to help clinicians in primary care. The AI improved the documentation. It pushed clinicians toward more guideline-concordant care. And it did nothing measurable for the patients. Treatment failure ran about 2 percent in the control group a

On July 15 the House Ways and Means Committee voted, unanimously, to make Medicare Advantage plans hand over a full list of everything they subject to prior authorization and report their denial data. CMS already forced the plans to decide expedited requests in 72 hours and standard ones in seven days starting this year. Plans now have to honor an approval once they give it, and they have to post

There's a study out in JAMA Network Open that should stop a lot of people mid-sentence. Researchers looked at roughly 16,000 Medicare fee-for-service patients, about 4,200 of them treated through hospital-at-home and the rest admitted the normal way. The hospital-at-home group did better on the things you'd hope. In-hospital mortality was 0.4% versus 3.6%. ED visits ran 8.8% versus 10%. ICU escala